RELENZA product monograph
Health-care Professional Information:
November 3, 2009 - Notice to Hospitals - Health Canada Endorsed Important Safety Information on PrRELENZA (zanamivir) Dry Powder for Inhalation
“Please read the “Consumer Information” leaflet for RELENZA located on this website as it contains important safety information on RELENZA.”
Trademarks are owned by or licensed to the GSK group of companies.